Rationale: Why this project exists.
Last updated
Last updated
Cancer continues to be one of the leading causes of death worldwide, claiming millions of lives annually. Despite advancements in medicine, critical research often faces delays due to bureaucratic obstacles, centralized systems, and inconsistent funding.
Recent developments in the U.S. underscore the urgency of this issue. In January 2025, the Trump Administration imposed sweeping restrictions on the National Institutes of Health (NIH), including halting grant reviews, freezing external communications, and pausing clinical trials. These disruptions threaten a $47.4 billion research ecosystem that supports groundbreaking cancer research, clinical trials, and innovative treatments. This funding freeze has left scientists, patients, and research institutions in a state of uncertainty, with life-saving work stalled indefinitely.
In response to these challenges, Free of CANCER was launched as a Decentralized Science (DeSci) initiative to revolutionize how cancer research is funded and executed. By leveraging blockchain technology, we aim to:
Eliminate Bureaucratic Barriers: Decentralization ensures faster, more efficient resource allocation without delays caused by traditional systems.
Promote Global Collaboration: Researchers from all over the world can join forces, share data, and work collectively toward breakthroughs.
Create Transparency: Blockchain technology ensures that every contribution, from funding to research milestones, is openly tracked and verified.
Incentivize Contributions: With a unique tokenomics model, we reward individuals and organizations contributing to cancer research, from scientists to sample providers.
This project is not just a reaction to current policies but a bold step toward a sustainable and inclusive future for cancer research. Cancer knows no borders, and the fight against it requires a united, global effort. Through Free of CANCER, we invite researchers, contributors, and supporters worldwide to join us in creating a future free of cancer. Together, we can accelerate innovation and make this vision a reality.
